Research Article

Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients

Journal of Medical Microbiology 2008; 57(4):439 · https://doi.org/10.1099/jmm.0.47499-0

Download PDF View at publisher PubMed

Summary auto-generated

Researchers developed an in-house loop-mediated isothermal amplification (LAMP) assay called MTB-LAMP to detect Mycobacterium tuberculosis using six primers targeting the 16S rRNA gene. The assay was evaluated on 200 sputum samples from Nepalese patients. MTB-LAMP demonstrated 100% sensitivity in culture-positive samples (96/96 samples), detecting all smear-positive and smear-negative culture-confirmed cases. In culture-negative samples, the assay showed 94.2% specificity (98/104 samples), with positive and negative predictive values of 94.1% and 100%, respectively. The primers were highly specific for the M. tuberculosis complex, showing no cross-reactivity with other mycobacterial species or non-mycobacterial bacteria tested. The detection limit was approximately 20 copies of M. tuberculosis DNA and 10 live bacteria in sputum samples. These results suggest MTB-LAMP could facilitate rapid tuberculosis diagnosis in resource-limited settings by combining the speed of microscopy with the sensitivity of bacterial culture.

Key findings

  • MTB-LAMP achieved 100% sensitivity in culture-positive sputum samples, detecting all 96 confirmed tuberculosis cases including both smear-positive and smear-negative specimens
  • The assay demonstrated 94.2% specificity in culture-negative samples with 100% negative predictive value, indicating reliable confirmation of negative cases
  • MTB-LAMP primers were highly specific for M. tuberculosis complex members with no cross-reactivity with other mycobacteria or common bacterial species tested
  • The assay can detect as few as 20 copies of M. tuberculosis DNA and approximately 10 live bacteria in processed sputum samples
  • MTB-LAMP offers advantages for tuberculosis diagnosis in developing countries by providing rapid results comparable to culture methods while maintaining high sensitivity

This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.

Abstract

1 Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal

2 Everest International Clinic and Research Center, Kathmandu, Nepal

3 Department of Microbiology, Tribhuban University, Kathmandu, Nepal

4 Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Japan

5 Asahi Kasei Co. Ltd, Shizuoka, Japan

6 Research Center for Zoonosis Control, Hokkaido University, Hokkaido, Japan

7 Department of Research and Biotechnology, Anandaban Hospital, Kathmandu, Nepal

8 Section of Bacterial Infections, Research Collaboration Center on Emerging and Re-emerging Infections, Osaka University, Nonthaburi, Thailand

9 National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand